603 related articles for article (PubMed ID: 16002216)
41. Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells.
Nuutinen T; Suuronen T; Kyrylenko S; Huuskonen J; Salminen A
Neurochem Int; 2005 Dec; 47(8):528-38. PubMed ID: 16157419
[TBL] [Abstract][Full Text] [Related]
42. In vivo application of histone deacetylase inhibitor trichostatin-a impairs murine male meiosis.
Fenic I; Hossain HM; Sonnack V; Tchatalbachev S; Thierer F; Trapp J; Failing K; Edler KS; Bergmann M; Jung M; Chakraborty T; Steger K
J Androl; 2008; 29(2):172-85. PubMed ID: 18046049
[TBL] [Abstract][Full Text] [Related]
43. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels.
Allritz C; Bette S; Figiel M; Engele J
Neurochem Int; 2009; 55(1-3):22-7. PubMed ID: 19428803
[TBL] [Abstract][Full Text] [Related]
44. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
45. Ketogenic diet decreases the level of proenkephalin mRNA induced by kainic acid in the mouse hippocampus.
Noh HS; Kim DW; Kang SS; Kim YH; Cho GJ; Choi WS
Neurosci Lett; 2006 Feb; 395(1):87-92. PubMed ID: 16300887
[TBL] [Abstract][Full Text] [Related]
46. Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A.
Zhong S; Goto H; Inagaki M; Dong Z
Oncogene; 2003 Aug; 22(34):5291-7. PubMed ID: 12917630
[TBL] [Abstract][Full Text] [Related]
47. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
[TBL] [Abstract][Full Text] [Related]
48. BDNF restores the expression of Jun and Fos inducible transcription factors in the rat brain following repetitive electroconvulsive seizures.
Hsieh TF; Simler S; Vergnes M; Gass P; Marescaux C; Wiegand SJ; Zimmermann M; Herdegen T
Exp Neurol; 1998 Jan; 149(1):161-74. PubMed ID: 9454625
[TBL] [Abstract][Full Text] [Related]
49. In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus.
Ogita K; Okuda H; Watanabe M; Nagashima R; Sugiyama C; Yoneda Y
Neuropharmacology; 2005 May; 48(6):810-21. PubMed ID: 15829253
[TBL] [Abstract][Full Text] [Related]
50. [Expression of proto-oncogenes c-fos and c-jun in osteoblasts activated by excessive fluoride].
Zhang WL; Cui YN; Gao S; Zhang XY; Li GS
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Jul; 37(4):246-50. PubMed ID: 12930673
[TBL] [Abstract][Full Text] [Related]
51. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
Hernandez M; Shao Q; Yang XJ; Luh SP; Kandouz M; Batist G; Laird DW; Alaoui-Jamali MA
Prostate; 2006 Aug; 66(11):1151-61. PubMed ID: 16652385
[TBL] [Abstract][Full Text] [Related]
52. Transcription factor activator protein-1 expressed by kainate treatment can bind to the non-coding region of mitochondrial genome in murine hippocampus.
Ogita K; Fujinami Y; Kitano M; Yoneda Y
J Neurosci Res; 2003 Sep; 73(6):794-802. PubMed ID: 12949905
[TBL] [Abstract][Full Text] [Related]
53. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
[TBL] [Abstract][Full Text] [Related]
54. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
55. Changes in histone acetylation during mouse oocyte meiosis.
Kim JM; Liu H; Tazaki M; Nagata M; Aoki F
J Cell Biol; 2003 Jul; 162(1):37-46. PubMed ID: 12835313
[TBL] [Abstract][Full Text] [Related]
56. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
Han S; Lu J; Zhang Y; Cheng C; Li L; Han L; Huang B
Immunol Lett; 2007 Feb; 108(2):143-50. PubMed ID: 17270283
[TBL] [Abstract][Full Text] [Related]
57. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina.
Wallace DM; Donovan M; Cotter TG
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2765-72. PubMed ID: 16799012
[TBL] [Abstract][Full Text] [Related]
58. Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.
Chittur SV; Sangster-Guity N; McCormick PJ
BMC Genomics; 2008 Oct; 9():507. PubMed ID: 18959802
[TBL] [Abstract][Full Text] [Related]
59. Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila.
Zhao Y; Lu J; Sun H; Chen X; Huang W; Tao D; Huang B
Biochem Biophys Res Commun; 2005 Jan; 326(4):811-6. PubMed ID: 15607742
[TBL] [Abstract][Full Text] [Related]
60. c-fos modulates brain-derived neurotrophic factor mRNA expression in mouse hippocampal CA3 and dentate gyrus neurons.
Dong M; Wu Y; Fan Y; Xu M; Zhang J
Neurosci Lett; 2006 May; 400(1-2):177-80. PubMed ID: 16530956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
